| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |